Quick Answer
AVENUE THERAPEUTICS, INC. reported Net Income Loss of -$2.91 million for the year ending 2025.
- AVENUE THERAPEUTICS, INC. showed an increase of +75.0% in Net Income Loss from 2024 to 2025.
- This data is from AVENUE THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2015 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2015 to 2025), AVENUE THERAPEUTICS, INC.'s Net Income Loss has grown by 44.3%.
- Historical annual values: Fiscal year 2025: -$2.91 million | Fiscal year 2024: -$11.65 million | Fiscal year 2022: -$3.55 million | Fiscal year 2021: -$3.73 million | Fiscal year 2020: -$5.15 million | Fiscal year 2019: -$25.91 million | Fiscal year 2018: -$21.55 million | Fiscal year 2017: -$12.26 million | Fiscal year 2016: -$3.18 million | Fiscal year 2015: -$5.23 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: